Pharmaceutical company Galderma has released new interim data from two ongoing investigator-initiated trials (IITs). The IITs presented results from Sculptra, a regenerative biostimulator, and the hyaluronic acid injectable Restylane range
Unlock natural, long-lasting beauty with Sculptra – the biostimulator that enhances skin quality and supports natural, youthful looking skin As patient expectations in medical aesthetics continue to evolve, there is a growing demand for treatments that go beyond short-term correction. …
Pharmaceutical company Galderma has been announced as the sponsor for the Best Clinic South England category at The Aesthetics Awards 2026. In the Galderma Award for Best Clinic South England,
The Aesthetics Journal attended IMCAS 2026 in collaboration with pharmaceutical company Galderma. Journalists were joined by aesthetic specialists – consultant dermatologists Dr Doris Day and Dr Sabrina Fabi, and consultant
The regenerative power of Sculptra for youthful-looking skin In the ever-evolving world of medical aesthetics, the demand for treatments that not only restore youthful contours but also improve the skin’s quality at a deeper level continues to grow. Pharmaceutical company …
Celebrating the 2026 Finalists Celebrated by the specialty as the pinnacle of recognition in medical aesthetics, The Aesthetics Awards is the flagship event that shines a light on those driving standards, safety and innovation. Each year, the event brings together …
Pharmaceutical company Galderma has announced the certification of Sculptra for body indications in the European Union (EU). The company shares that this certification under the EU Medical Device Regulation (MDR)
Aesthetic manufacturer Crown Aesthetics has appointed Joanna Neal as marketing manager for the UK and Ireland. Going forward, Neal will be leading marketing activity for SkinPen and Biojuve. Neal previously
Pharmaceutical company Galderma has announced that the US Food and Drug Administration (FDA) has approved Restylane Lyft for the augmentation for the chin region. The company shares that the combination
Aesthetic manufacturer Teoxane has introduced Joanna Underhill as new general manager for the UK&I. Teoxane shares that Underhill joins the company from pharmaceutical company Allergan Aesthetics, an AbbVie company, where